大型多发性硬化症数据网络:用于真实世界数据分析的新型建模方法
M Trojano1, P Iaffaldano2, M Copetti3
1Department of Translational Biomedicine and Neurosciences -DiBrain, University of Bari "Aldo Moro", Piazza Umberto I, 70121, Bari, Italy. maria.trojano@uniba.it.
Journal of neurology
|November 8, 2025
概括
先进的统计和机器学习使用现实世界的数据 (RWD) 改善了多发性硬化症 (MS) 治疗预测. 这些方法提高了对比有效性,安全分析和数据协调,用于MS的精准医学.
科学领域:
- 统计方法学的统计方法.
- 现实世界的数据分析分析.
- 多发性硬化症的研究.
背景情况:
- 大型多发性硬化症数据 (BMSD) 网络于2023年6月在意大利巴里召开了一场研讨会.
- 研讨会的重点是分析多发性硬化症 (MS) 现实世界数据 (RWD) 的先进统计方法.
- 该BMSD网络包括五个国家注册表和国际MSBase数据库,涵盖超过35万名患者.
研究的目的:
- 报告BMSD统计工作坊的成果.
- 突出国家/地区RWD分析的先进统计方法.
- 讨论这些方法在预测治疗反应,比较有效性,安全性和数据统一统一分析中的应用.
主要方法:
- 专家们审查了频率主义,贝叶斯主义和机器学习 (ML) 方法用于RWD分析.
- 案例研究包括治疗反应建模,比较有效性,安全监测和基于共同数据模型 (CDM) 的联合学习.
- 讨论涵盖了各种统计技术的优点,局限性和监管影响.
主要成果:
- 贝叶斯和ML技术,结合因果推理,通过使用纵向数据,增强对治疗益处和风险的个性化预测.
- 倾向评分方法和边际结构模型对于尽量减少对比分析中的混至关重要.
- 共同数据模型 (CDM) 有助于协调各种数据集,而联合学习可以进行保护隐私的协作分析.
结论:
- 先进的统计和计算方法提高了MS RWD研究的稳定性,可解释性和监管相关性.
- 在协调的数据基础设施中整合互补的统计方法可以加速将现实世界的证据转化为MS的精准医学.
- BMSD网络正在推动RWD用于基于证据的MS护理.
相关概念视频
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
228
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
228
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
472
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
472
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
309
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
309
Statistical Methods for Analyzing Epidemiological Data
888
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
888


